Definitive Healthcare (DH) Common Equity (2020 - 2026)
Definitive Healthcare filings provide 6 years of Common Equity readings, the most recent being $379.0 million for Q4 2025.
- On a quarterly basis, Common Equity fell 37.58% to $379.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $379.0 million, a 37.58% decrease, with the full-year FY2025 number at $379.0 million, down 37.58% from a year prior.
- Common Equity hit $379.0 million in Q4 2025 for Definitive Healthcare, down from $389.7 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $1.5 billion in Q4 2021 to a low of $379.0 million in Q4 2025.
- Median Common Equity over the past 5 years was $1.2 billion (2023), compared with a mean of $1.1 billion.
- Biggest five-year swings in Common Equity: surged 1145012.98% in 2021 and later tumbled 63.52% in 2025.
- Definitive Healthcare's Common Equity stood at $1.5 billion in 2021, then fell by 1.19% to $1.5 billion in 2022, then decreased by 19.08% to $1.2 billion in 2023, then tumbled by 49.37% to $607.2 million in 2024, then plummeted by 37.58% to $379.0 million in 2025.
- The last three reported values for Common Equity were $379.0 million (Q4 2025), $389.7 million (Q3 2025), and $411.2 million (Q2 2025) per Business Quant data.